Literature DB >> 19581354

5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size.

Rebecca M Lindell1, Thomas E Hartman2, Stephen J Swensen2, James R Jett3, David E Midthun3, Jayawant N Mandrekar4.   

Abstract

BACKGROUND: Although no study has prospectively documented the rate at which lung cancers grow, many have assumed exponential growth. The purpose of this study was to document the growth of lung cancers detected in high-risk participants receiving annual screening chest CT scans.
METHODS: Eighteen lung cancers were evaluated by at least four serial CT scans (4 men, 14 women; age range, 53 to 79 years; mean age, 66 years). CT scans were retrospectively reviewed for appearance, size, and volume (volume [v] = pi/6[ab(2)]). Growth curves (x = time [in days]; y = volume [cubic millimeters]) were plotted and subcategorized by histology, CT scan attenuation, stage, survival, and initial size.
RESULTS: Inclusion criteria favored smaller, less aggressive cancers. Growth curves varied, even when subcategorized by histology, CT scan attenuation, stage, survival, or initial size. Cancers associated with higher stages, mortality, or recurrence showed fairly steady growth or accelerated growth compared with earlier growth, although these growth patterns also were seen in lesser-stage lung cancers. Most lung cancers enlarged at fairly steady increments, but several demonstrated fairly flat growth curves, and others demonstrated periods of accelerated growth.
CONCLUSIONS: This study is the first to plot individual lung cancer growth curves. Although parameters favored smaller, less aggressive cancers in women, it showed that lung cancers are not limited to exponential growth. Tumor size at one point or growth between two points did not appear to predict future growth. Studies and equations assuming exponential growth may potentially misrepresent an indeterminate nodule or the aggressiveness of a lung cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19581354      PMCID: PMC2789925          DOI: 10.1378/chest.09-0915

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Gompertzian growth pattern correlated with phenotypic organization of colon carcinoma, malignant glioma and non-small cell lung carcinoma cell lines.

Authors:  M A A Castro; F Klamt; V A Grieneisen; I Grivicich; J C F Moreira
Journal:  Cell Prolif       Date:  2003-04       Impact factor: 6.831

2.  A biomathematical approach to clinical tumor growth.

Authors:  M SCHWARTZ
Journal:  Cancer       Date:  1961 Nov-Dec       Impact factor: 6.860

3.  Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.

Authors:  Rebecca M Lindell; Thomas E Hartman; Stephen J Swensen; James R Jett; David E Midthun; Henry D Tazelaar; Jayawant N Mandrekar
Journal:  Radiology       Date:  2007-02       Impact factor: 11.105

4.  Growth rate of small lung cancers detected on mass CT screening.

Authors:  M Hasegawa; S Sone; S Takashima; F Li; Z G Yang; Y Maruyama; T Watanabe
Journal:  Br J Radiol       Date:  2000-12       Impact factor: 3.039

5.  The natural history of lung cancer: a review based on rates of tumour growth.

Authors:  D M Geddes
Journal:  Br J Dis Chest       Date:  1979-01

6.  Estimating the growth rates of primary lung tumours from samples with missing measurements.

Authors:  Olga Gorlova; Bo Peng; David Yankelevitz; Claudia Henschke; Marek Kimmel
Journal:  Stat Med       Date:  2005-04-15       Impact factor: 2.373

7.  Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements.

Authors:  S Gregory Jennings; Helen T Winer-Muram; Mark Tann; Jun Ying; Ian Dowdeswell
Journal:  Radiology       Date:  2006-09-27       Impact factor: 11.105

8.  CT screening for lung cancer: five-year prospective experience.

Authors:  Stephen J Swensen; James R Jett; Thomas E Hartman; David E Midthun; Sumithra J Mandrekar; Shauna L Hillman; Anne-Marie Sykes; Gregory L Aughenbaugh; Aaron O Bungum; Katie L Allen
Journal:  Radiology       Date:  2005-02-04       Impact factor: 11.105

9.  Tumor doubling time and prognostic assessment of patients with primary lung cancer.

Authors:  K Usuda; Y Saito; M Sagawa; M Sato; K Kanma; S Takahashi; C Endo; Y Chen; A Sakurada; S Fujimura
Journal:  Cancer       Date:  1994-10-15       Impact factor: 6.860

10.  The universal dynamics of tumor growth.

Authors:  Antonio Brú; Sonia Albertos; José Luis Subiza; José López García-Asenjo; Isabel Brú
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

View more
  19 in total

1.  Evaluating the growth of pulmonary nodular ground-glass opacity on CT: comparison of volume rendering and thin slice images.

Authors:  Mingzhu Liang; Xueguo Liu; Weidong Li; Kunwei Li; Xiangmeng Chen; Guojie Wang; Kai Chen; Jinxin Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

2.  In vivo growth of 60 non-screening detected lung cancers: a computed tomography study.

Authors:  Onno M Mets; Kaman Chung; Pieter Zanen; Ernst T Scholten; Wouter B Veldhuis; Bram van Ginneken; Mathias Prokop; Cornelia M Schaefer-Prokop; Pim A de Jong
Journal:  Eur Respir J       Date:  2018-04-12       Impact factor: 16.671

3.  Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.

Authors:  William D Hazelton; Gary Goodman; William N Rom; Melvyn Tockman; Mark Thornquist; Suresh Moolgavkar; Joel L Weissfeld; Ziding Feng
Journal:  Math Biosci       Date:  2012-06-15       Impact factor: 2.144

4.  Pulmonary Nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry.

Authors:  Jane P Ko; Erika J Berman; Manmeen Kaur; James S Babb; Elan Bomsztyk; Alissa K Greenberg; David P Naidich; Henry Rusinek
Journal:  Radiology       Date:  2011-12-09       Impact factor: 11.105

Review 5.  Screening for early stage lung cancer and its correlation with lung nodule detection.

Authors:  Fangfei Qian; Wenjia Yang; Qunhui Chen; Xueyan Zhang; Baohui Han
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

6.  Overdiagnosis in low-dose computed tomography screening for lung cancer.

Authors:  Edward F Patz; Paul Pinsky; Constantine Gatsonis; Jorean D Sicks; Barnett S Kramer; Martin C Tammemägi; Caroline Chiles; William C Black; Denise R Aberle
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

7.  Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT.

Authors:  Jingbo Wang; Pawinee Mahasittiwat; Ka Kit Wong; Leslie E Quint; Feng-Ming Spring Kong
Journal:  Lung Cancer       Date:  2012-07-28       Impact factor: 5.705

Review 8.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Malignant solitary pulmonary nodules: assessment of mass growth rate and doubling time at follow-up CT.

Authors:  Jingxu Li; Tingting Xia; Xinguan Yang; Xiao Dong; Jiamin Liang; Nanshan Zhong; Yubao Guan
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

10.  Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies.

Authors:  Susan Fernandes; Gareth Williams; Elvira Williams; Katjana Ehrlich; James Stone; Neil Finlayson; Mark Bradley; Robert R Thomson; Ahsan R Akram; Kevin Dhaliwal
Journal:  Eur Respir J       Date:  2021-03-25       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.